Skip to main content

Published locations for Gefitinib approved for first-line EGFR-positive metastatic NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Gefitinib approved for first-line EGFR-positive metastatic NSCLC

User login

  • Reset your password
  • /content/gefitinib-approved-first-line-egfr-positive-metastatic-nsclc
  • /oncologypractice/article/101247/lung-cancer/gefitinib-approved-first-line-egfr-positive-metastatic
  • /hematology-oncology/article/101247/lung-cancer/gefitinib-approved-first-line-egfr-positive
  • /chestphysician/article/101247/lung-cancer/gefitinib-approved-first-line-egfr-positive-metastatic